Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical trial design

S B King1

  • 1Andreas Gruentzig Cardiovascular Center, Emory University Hospital, Atlanta, GA 30322, USA.

Seminars in Interventional Cardiology : SIIC
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Radiation therapy trials offer a unique chance to evaluate device therapies in a blinded setting. Moderate clinical trials can effectively assess restenosis reduction, with blinding crucial for validating clinical outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Disease of Pearl Millet in Zimbabwe Caused by Pantoea agglomerans.

Plant disease·2019
Same author

Prevalence, Incidence, and Severity of Sorghum Diseases in Western Kenya.

Plant disease·2019
Same author

A randomized, controlled, single-blinded, multicenter evaluation of the efficacy and safety of a once weekly two dose otic gel containing florfenicol, terbinafine and betamethasone administered for the treatment of canine otitis externa.

BMC veterinary research·2018
Same author

A randomized placebo-controlled trial of the efficacy and safety of a terbinafine, florfenicol and betamethasone topical ear formulation in dogs for the treatment of bacterial and/or fungal otitis externa.

BMC veterinary research·2018
Same author

Reconstruction of primary vertices at the ATLAS experiment in Run 1 proton-proton collisions at the LHC.

The European physical journal. C, Particles and fields·2017
Same author

Topological cell clustering in the ATLAS calorimeters and its performance in LHC Run 1.

The European physical journal. C, Particles and fields·2017
Same journal

Atherectomy plus stenting: what do we gain?

Seminars in interventional cardiology : SIIC·2001
Same journal

The place of directional coronary atherectomy for the treatment of in-stent restenosis.

Seminars in interventional cardiology : SIIC·2001
Same journal

The place of rotablator for treatment of in-stent restenosis.

Seminars in interventional cardiology : SIIC·2001
Same journal

Directional coronary atherectomy: optimal atherectomy trials and new combined strategies with coronary stents.

Seminars in interventional cardiology : SIIC·2001
Same journal

Further insights into coronary debulking: the EUROCARE trial of directional atherectomy and the PACT trial of pullback atherectomy.

Seminars in interventional cardiology : SIIC·2001
Same journal

Morphological analysis of atherosclerotic plaque retrieved by coronary atherectomy.

Seminars in interventional cardiology : SIIC·2001
See all related articles

Area of Science:

  • Cardiovascular medicine
  • Interventional cardiology
  • Medical device technology

Background:

  • Restenosis remains a significant complication after vascular interventions.
  • Existing observational studies suggest potential efficacy of device-based therapies.
  • Blinded clinical trials are needed to rigorously evaluate these interventions.

Purpose of the Study:

  • To assess the efficacy of a device therapy in reducing restenosis.
  • To explore the potential of blinded clinical trials for evaluating such therapies.
  • To investigate the mechanisms underlying restenosis reduction.

Main Methods:

  • Conducting blinded clinical trials.
  • Utilizing moderate-sized trial designs.
  • Employing angiographic and intravascular ultrasound for mechanistic studies.

Related Experiment Videos

Main Results:

  • Blinded trials provide a robust method for evaluating device therapy efficacy.
  • Moderate-sized trials are sufficient for assessing restenosis reduction.
  • Angiography and intravascular ultrasound are key for mechanistic insights.

Conclusions:

  • Blinded clinical trials are essential for validating device therapies.
  • Device therapies show promise in reducing restenosis.
  • Further mechanistic studies using advanced imaging are warranted.